Israel
· Delayed Price · Currency is ILS · Price in ILA HomeBiogas Statistics
Total Valuation
HomeBiogas has a market cap or net worth of ILS 30.69 million. The enterprise value is 22.07 million.
| Market Cap | 30.69M |
| Enterprise Value | 22.07M |
Important Dates
The last earnings date was Wednesday, March 19, 2025.
| Earnings Date | Mar 19, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
HomeBiogas has 24.13 million shares outstanding. The number of shares has increased by 17.69% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 24.13M |
| Shares Change (YoY) | +17.69% |
| Shares Change (QoQ) | -0.32% |
| Owned by Insiders (%) | 9.49% |
| Owned by Institutions (%) | 21.12% |
| Float | 13.26M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.19 |
| PB Ratio | 1.68 |
| P/TBV Ratio | 2.04 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.64 |
| EV / Sales | 2.30 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -1.29 |
Financial Position
The company has a current ratio of 2.36, with a Debt / Equity ratio of 0.09.
| Current Ratio | 2.36 |
| Quick Ratio | 1.86 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.10 |
| Interest Coverage | -66.10 |
Financial Efficiency
Return on equity (ROE) is -99.03% and return on invested capital (ROIC) is -55.48%.
| Return on Equity (ROE) | -99.03% |
| Return on Assets (ROA) | -43.04% |
| Return on Invested Capital (ROIC) | -55.48% |
| Return on Capital Employed (ROCE) | -165.47% |
| Revenue Per Employee | 138,830 |
| Profits Per Employee | -497,200 |
| Employee Count | 69 |
| Asset Turnover | 0.19 |
| Inventory Turnover | 1.82 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -68.16% in the last 52 weeks. The beta is 0.04, so HomeBiogas's price volatility has been lower than the market average.
| Beta (5Y) | 0.04 |
| 52-Week Price Change | -68.16% |
| 50-Day Moving Average | 139.24 |
| 200-Day Moving Average | 131.06 |
| Relative Strength Index (RSI) | 46.21 |
| Average Volume (20 Days) | 117,587 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HomeBiogas had revenue of ILS 9.58 million and -34.31 million in losses. Loss per share was -1.43.
| Revenue | 9.58M |
| Gross Profit | 1.40M |
| Operating Income | -34.67M |
| Pretax Income | -34.29M |
| Net Income | -34.31M |
| EBITDA | -30.89M |
| EBIT | -34.67M |
| Loss Per Share | -1.43 |
Balance Sheet
The company has 10.33 million in cash and 1.71 million in debt, giving a net cash position of 8.62 million or 0.36 per share.
| Cash & Cash Equivalents | 10.33M |
| Total Debt | 1.71M |
| Net Cash | 8.62M |
| Net Cash Per Share | 0.36 |
| Equity (Book Value) | 18.16M |
| Book Value Per Share | 0.76 |
| Working Capital | 12.18M |
Cash Flow
In the last 12 months, operating cash flow was -16.44 million and capital expenditures -630,118, giving a free cash flow of -17.07 million.
| Operating Cash Flow | -16.44M |
| Capital Expenditures | -630,118 |
| Free Cash Flow | -17.07M |
| FCF Per Share | -0.71 |
Margins
| Gross Margin | 14.60% |
| Operating Margin | -361.90% |
| Pretax Margin | -357.95% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
HomeBiogas does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -17.69% |
| Shareholder Yield | -17.69% |
| Earnings Yield | -111.79% |
| FCF Yield | -55.62% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |